Crinetics Pharmaceuticals Inc.
CRNX
|
|
| |
|
| Trading Volume | 14,975 |
|
|
54.47 - 15.97 |
| Market Cap Full | $ 3.5B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 4.1% | 31.5% | -12.2% | -22.7% |
| Q2 | - | -6.5% | 12.2% | -15% |
| Q3 | - | -1% | 65% | 5.3% |
| Q4 | - | -9.8% | 31.1% | -6.8% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 2.5 | 12.2 | 14.2 | -8.1 | 3.4 | -2.1 | 22.4 | -1 | - | - | - | - |
| 2023 | |||||||||||
| 7.2 | 0.2 | -18.2 | 21.7 | 11.7 | -17.5 | 5.4 | -8.8 | 71.7 | -1.5 | 8.5 | 11.9 |
| 2022 | |||||||||||
| -33.8 | 5.1 | 11.1 | -8.2 | -16.9 | 11.3 | 3 | -1.7 | 4 | -6 | -3.2 | 2.4 |
| 2021 | |||||||||||
| 8 | 0.3 | -0.1 | 13.3 | 1.4 | 7.4 | -4.6 | 31.1 | -11.3 | 19.3 | 1.9 | 11.8 |
| 2020 | |||||||||||
| -12.2 | -4.2 | -28.6 | 13.5 | -2 | 7.2 | -20.8 | 15.5 | -2.3 | -22.7 | 8.6 | 7.2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.9 | -0.7 | -0.7 | -0.7 |
| Q2 | -0.9 | -0.8 | -0.7 | -0.5 |
| Q3 | -1 | -0.8 | -0.7 | -0.6 |
| Q4 | 0 | -0.8 | -0.7 | -0.6 |
| A | -2.8 | -3.2 | -2.8 | -2.4 |